About ARISAN THERAPEUTICS INC
Arisan Therapeutics is a clinical stage company focused on the development of convenient, small molecule oral therapeutics for neglected and emerging viral diseases, including priority biodefense-related pathogens. The company collaborates with organizations such as the Defense Threat Reduction Agency (DTRA), Battelle Memorial Institute, and the National Institute for Allergy and Infectious Disease (NIAID).
Development of small molecule oral therapeutics for neglected and emerging viral diseasesCollaboration with government and research institutionsDrug discovery and development experience
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| TO CONDUCT NON-CLINICAL GOOD LABORATORY PRACTICE (GLP) IN VIVO GENOTOXICITY AND REPRODUCTIVE TOXICOLOGY AND GL | Department of Health and Human Services | $3.7M | |
| Federal contract award | Department of Defense | $1.1M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ARISAN THERAPEUTICS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.